UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Neurogenic abnormalities in Alzheimer's disease differ between stages of neurogenesis and are partly related to cholinergic pathology

Neurobiology of disease, 2012-08, Vol.47 (2), p.155-162

2012

Volltextzugriff (PDF)

Alzheimer's disease and vascular dementia in developing countries: prevalence, management, and risk factors

Lancet neurology, 2008-09, Vol.7 (9), p.812-826

2008

Volltextzugriff (PDF)

Salvia for dementia therapy: review of pharmacological activity and pilot tolerability clinical trial

Pharmacology, Biochemistry and Behavior, 2003-06, Vol.75 (3), p.651-659

2003

Volltextzugriff (PDF)

Increased Alzheimer pathology in Parkinson's disease related to antimuscarinic drugs

Annals of neurology, 2003-08, Vol.54 (2), p.235-238

2003

Volltextzugriff (PDF)

In-vitro Inhibition of Human Erythrocyte Acetylcholinesterase by Salvia lavandulaefolia Essential Oil and Constituent Terpenes

Journal of pharmacy and pharmacology, 2000-07, Vol.52 (7), p.895-902

2000

Volltextzugriff (PDF)

Cholinergic Activity in Autism: Abnormalities in the Cerebral Cortex and Basal Forebrain

The American journal of psychiatry, 2001-07, Vol.158 (7), p.1058-1066

2001

Volltextzugriff (PDF)

Role of phytochemicals as nutraceuticals for cognitive functions affected in ageing

British journal of pharmacology, 2020-03, Vol.177 (6), p.1294-1315

2020

Volltextzugriff (PDF)

Medicinal Plants and Alzheimer's Disease: from Ethnobotany to Phytotherapy

Journal of pharmacy and pharmacology, 1999-05, Vol.51 (5), p.527-534

1999

Volltextzugriff (PDF)

Stage-Specific Changes in Neurogenic and Glial Markers in Alzheimer’s Disease

Biological psychiatry (1969), 2015-04, Vol.77 (8), p.711-719

2015

Volltextzugriff (PDF)

Cholinergic and other neurotransmitter mechanisms in Parkinson's disease, Parkinson's disease dementia, and dementia with Lewy bodies

Movement disorders, 2007, Vol.22 (S17), p.S351-S357

2007

Volltextzugriff (PDF)

Partial loss of parvalbumin-containing hippocampal interneurons in dementia with Lewy bodies

Neuropathology, 2011-02, Vol.31 (1), p.1-10

2011

Volltextzugriff (PDF)

Dementia rating and nicotinic receptor expression in the prefrontal cortex in schizophrenia

Biological psychiatry (1969), 2003-12, Vol.54 (11), p.1222-1233

2003

Volltextzugriff (PDF)

Cerebrospinal Fluid Biomarkers for Dementia with Lewy Bodies

International journal of alzheimer's disease, 2010, Vol.2010 (2010), p.1-17

2010

Volltextzugriff (PDF)

Aromatherapy as a safe and effective treatment for the management of agitation in severe dementia: the results of a double-blind, placebo-controlled trial with Melissa

The journal of clinical psychiatry, 2002-07, Vol.63 (7), p.553

2002

Volltextzugriff (PDF)

Neuroleptic sensitivity in Parkinson's disease and parkinsonian dementias

The journal of clinical psychiatry, 2005-05, Vol.66 (5), p.633-514

2005

Volltextzugriff (PDF)

Synaptic Proteins and Choline Acetyltransferase Loss in Visual Cortex in Dementia With Lewy Bodies

Journal of neuropathology and experimental neurology, 2013-01, Vol.72 (1), p.53-60

2013

Volltextzugriff (PDF)

Neocortical cholinergic activities differentiate Lewy body dementia from classical Alzheimerʼs disease

Neuroreport, 1994-03, Vol.5 (7), p.747-749

1994

Volltextzugriff (PDF)

An extract of Salvia (sage) with anticholinesterase properties improves memory and attention in healthy older volunteers

Psychopharmacologia, 2008-05, Vol.198 (1), p.127-139

2008

Volltextzugriff (PDF)

Butyryl- and acetyl-cholinesterase inhibitory activities in essential oils of Salvia species and their constituents

Phytotherapy research, 2004-04, Vol.18 (4), p.315-324

2004

Volltextzugriff (PDF)

The effect of drug treatment on neurogenesis in Parkinson's disease

Movement disorders, 2011-01, Vol.26 (1), p.45-50

2011

Volltextzugriff (PDF)

Increased neural progenitors in vascular dementia

Neurobiology of aging, 2011-12, Vol.32 (12), p.2152-2161

2011

Volltextzugriff (PDF)

Neurogenic marker abnormalities in the hippocampus in dementia with Lewy bodies

Hippocampus, 2011-10, Vol.21 (10), p.1126-1136

2011

Volltextzugriff (PDF)

Neuropathological Substrates of Psychiatric Symptoms in Prospectively Studied Patients With Autopsy-Confirmed Dementia With Lewy Bodies

The American journal of psychiatry, 2004-05, Vol.161 (5), p.843-849

2004

Volltextzugriff (PDF)

Dynamin protein in stroke and vascular dementia

Neuroscience letters, 2014-03, Vol.563, p.118-122

2014

Volltextzugriff (PDF)

Pharmacological profile of essential oils derived from Lavandula angustifolia and Melissa officinalis with anti-agitation properties: focus on ligand-gated channels

Journal of pharmacy and pharmacology, 2008-11, Vol.60 (11), p.1515-1522

2008

Volltextzugriff (PDF)

1 – 25 von 239

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(228)
Mit Volltextzugriff
(209)

Publikationsform

Sprache

Englisch
(239)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Neurogenic abnormalities in Alzheimer's disease differ between stages of neurogenesis and are partly related to cholinergic pathology

Alzheimer's disease and vascular dementia in developing countries: prevalence, management, and risk factors

Salvia for dementia therapy: review of pharmacological activity and pilot tolerability clinical trial

Increased Alzheimer pathology in Parkinson's disease related to antimuscarinic drugs

In-vitro Inhibition of Human Erythrocyte Acetylcholinesterase by Salvia lavandulaefolia Essential Oil and Constituent Terpenes

Cholinergic Activity in Autism: Abnormalities in the Cerebral Cortex and Basal Forebrain

Role of phytochemicals as nutraceuticals for cognitive functions affected in ageing

Medicinal Plants and Alzheimer's Disease: from Ethnobotany to Phytotherapy

Stage-Specific Changes in Neurogenic and Glial Markers in Alzheimer’s Disease

Cholinergic and other neurotransmitter mechanisms in Parkinson's disease, Parkinson's disease dementia, and dementia with Lewy bodies

Partial loss of parvalbumin-containing hippocampal interneurons in dementia with Lewy bodies

Dementia rating and nicotinic receptor expression in the prefrontal cortex in schizophrenia

Cerebrospinal Fluid Biomarkers for Dementia with Lewy Bodies

Aromatherapy as a safe and effective treatment for the management of agitation in severe dementia: the results of a double-blind, placebo-controlled trial with Melissa

Neuroleptic sensitivity in Parkinson's disease and parkinsonian dementias

Synaptic Proteins and Choline Acetyltransferase Loss in Visual Cortex in Dementia With Lewy Bodies

Neocortical cholinergic activities differentiate Lewy body dementia from classical Alzheimerʼs disease

An extract of Salvia (sage) with anticholinesterase properties improves memory and attention in healthy older volunteers

Butyryl- and acetyl-cholinesterase inhibitory activities in essential oils of Salvia species and their constituents

The effect of drug treatment on neurogenesis in Parkinson's disease

Increased neural progenitors in vascular dementia

Neurogenic marker abnormalities in the hippocampus in dementia with Lewy bodies

Neuropathological Substrates of Psychiatric Symptoms in Prospectively Studied Patients With Autopsy-Confirmed Dementia With Lewy Bodies

Dynamin protein in stroke and vascular dementia

Pharmacological profile of essential oils derived from Lavandula angustifolia and Melissa officinalis with anti-agitation properties: focus on ligand-gated channels

Suchergebnisse filtern